PharmiWeb.com - Global Pharma News & Resources
30-Aug-2018

Herantis Pharma Oyj: Manager's Transactions - Aki Prihti

Herantis Pharma Oyj: Manager's Transactions - Aki Prihti

Herantis Pharma Plc
Company release 30 Aug 2018 at 9:00 am

Herantis Pharma Oyj - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Prihti, Aki

Position: Member of the Board/Deputy member

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20180828114149_2

____________________________________________

Transaction date: 2018-08-29

Venue not applicable

Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT

Instrument name: Optio-ohjelma 2014 I (Optio- ja muut erityiset oikeudet P003)

Nature of the transaction: ACCEPTANCE OF A STOCK OPTION

(X) Linked to stock option programme

Transaction details

(1): Volume: 6 Unit price:  0.00 EUR

Aggregated transactions

(1): Volume: 6 Volume weighted average price:  0.00 EUR

____________________________________________

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225

Distribution:

Nasdaq Helsinki
Main media
www.herantis.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Herantis Pharma Oyj via GlobeNewswire
HUG#2213028

Editor Details

Last Updated: 31-Aug-2018